National Health Investors, Inc. (NYSE:NHI) Given Consensus Recommendation of “Moderate Buy” by Analysts

National Health Investors, Inc. (NYSE:NHI) has received an average rating of “Moderate Buy” from the eight research firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have given a buy recommendation to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $83.8571.

A number of equities research analysts recently issued reports on NHI shares. BMO Capital Markets lowered their price objective on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research note on Monday, June 15th. Weiss Ratings lowered shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Zacks Research downgraded shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. Truist Financial lowered their price target on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a research report on Friday, June 12th. Finally, Wells Fargo & Company dropped their price target on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a research note on Monday, June 1st.

Insiders Place Their Bets

In related news, CEO D. Eric Mendelsohn bought 1,500 shares of the company’s stock in a transaction on Friday, June 5th. The shares were purchased at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the transaction, the chief executive officer directly owned 133,316 shares in the company, valued at approximately $9,177,473.44. The trade was a 1.14% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Robert A. Mccabe, Jr. bought 890 shares of the company’s stock in a transaction on Monday, June 15th. The shares were bought at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the transaction, the director owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. This represents a 2.06% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders own 2.70% of the company’s stock.

Institutional Trading of National Health Investors

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Principal Financial Group Inc. grew its position in National Health Investors by 1.9% during the 4th quarter. Principal Financial Group Inc. now owns 1,668,006 shares of the real estate investment trust’s stock worth $127,386,000 after acquiring an additional 30,968 shares during the last quarter. Sound Income Strategies LLC lifted its position in National Health Investors by 6.5% in the fourth quarter. Sound Income Strategies LLC now owns 256,898 shares of the real estate investment trust’s stock valued at $20,595,000 after purchasing an additional 15,638 shares during the last quarter. Aberdeen Group plc lifted its position in National Health Investors by 73.7% in the fourth quarter. Aberdeen Group plc now owns 45,355 shares of the real estate investment trust’s stock valued at $3,464,000 after purchasing an additional 19,241 shares during the last quarter. Tudor Investment Corp ET AL lifted its position in National Health Investors by 189.8% in the third quarter. Tudor Investment Corp ET AL now owns 116,570 shares of the real estate investment trust’s stock valued at $9,267,000 after purchasing an additional 76,339 shares during the last quarter. Finally, M&T Bank Corp purchased a new stake in shares of National Health Investors during the fourth quarter valued at approximately $2,996,000. 62.51% of the stock is currently owned by institutional investors.

National Health Investors Stock Up 0.2%

Shares of NYSE NHI opened at $79.76 on Monday. The company has a debt-to-equity ratio of 0.83, a current ratio of 8.20 and a quick ratio of 8.20. The stock has a market capitalization of $3.87 billion, a PE ratio of 25.73, a P/E/G ratio of 3.57 and a beta of 0.51. National Health Investors has a one year low of $67.94 and a one year high of $91.38. The business’s fifty day moving average price is $74.45 and its 200-day moving average price is $79.62.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Tuesday, June 30th will be paid a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date is Tuesday, June 30th. National Health Investors’s payout ratio is currently 118.71%.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.